Bruker Corporation (BRKR)
Last Price$44.5(0.0%)
Market Cap$6,738.6M
BRKR Rating
BRKR Quality rating performance
BRKR Intrinsic Value
Key Highlights:
As of Mar 21, 2025 BRKR Relative Value is $80.1, which is undervalued by 80.1%, compared to current share price of $44.5.
As of Mar 21, 2025 BRKR DCF Value is $7.9, which is overvalued by 82.1%, compared to current share price of $44.5.
BRKR Share Price History
1W (3.2%)
1M (12.5%)
6M (33.8%)
YTD (38.3%)
1Y (52.7%)
3Y (33.7%)
5Y 41.5%
10Y 140.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
BRKR Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$6,738.6M
$8,649.5M
$3,366.4M
$136.0M
Shares Outstanding
152M
Employees
67
Growth (CAGR)
10.2%
(0.5%)
(9.62%)
(0.6%)
250.27%
Profitability
49.0%
8.7%
7.5%
4.0%
119.5%
Intrinsic Value
$44.0 (1.1% overvalued)
$7.9
$80.0
$170.3
18.8%
Return on Capital
Financial Health
$1,910.9M
14.1x
5.9x
115.4%
Dividends
5.0%
0.4%
22.1%
Mar 17, 2025
Earnings
Aug 04, 2025
BEAT by 1.4%
BEAT by 1.3%
72.7%
8 Beat & 2 Miss
BRKR Stock Financials
BRKR Income Statement Metrics
Annual
Quarterly
LTM
BRKR Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$251.3M -28.2% YoY
Capital Expenditure (CAPEX)
($115.3M) +7.9% YoY
Free Cash Flow (FCF)
$136.0M -44.1% YoY
BRKR Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$3,366.4M 13.6% YoY
Cost of revenue
$1,716.9M 18.3% YoY
Pre-tax income
$204.5M (62.4%) YoY
6.1% margin
BRKR Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$5,806.7M
Current assets ($2,053.2M, 35.4% of total)
$183.4M (3.2%)
$565.5M (9.7%)
Other current assets
$1,304.3M (22.5%)
Non-current assets ($3,753.5M, 64.6% of total)
$0.0 (0.0%)
$814.8M (14.0%)
$912.5M (15.7%)
Other non-current assets
$2,026.2M (34.9%)
Financial position
$2,029.8M
Cash & Short-term
Investments
Total Debt
BRKR Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
BRKR Earnings Surprises
Crunching data... Almost there!
BRKR Dividends
BRKR Dividend Yield
Crunching data... Almost there!
BRKR Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with BRKR
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$6,738.6M | 5.2 | $44.0 1.1% overvalued | (52.7%) | $3,366.4M | $136.0M | 13.6% | 4.0% | 49.0% | 4.4% | 115.4% | |
$218.8B | 7.1 | $187.7 48.6% undervalued | 15.6% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$148.2B | 6.8 | $37.4 62.9% overvalued | 49.0% | $16.7B | $2,438.0M | 17.6% | 14.6% | 67.0% | 8.0% | 50.7% | |
$141.4B | 6.7 | $305.8 17.6% overvalued | 5.9% | $22.6B | $3,487.0M | 10.2% | 15.4% | 62.8% | 10.4% | 65.9% | |
$115.8B | 6.4 | $122.4 35.5% undervalued | 11.1% | $33.2B | $5,467.0M | 2.7% | 16.5% | 62.9% | 7.4% | 53.6% | |
$41.6B | 6.1 | $56.4 20.0% overvalued | (25.6%) | $5,724.3M | $289.9M | (4.7%) | 5.1% | 78.4% | 21.6% | 7.0% | |
$29.5B | 7.3 | $40.2 45.6% overvalued | (44.7%) | $4,033.0M | $630.7M | 11.3% | 15.6% | 60.4% | 21.7% | 120.3% | |
$23.6B | 5.3 | $72.8 185.6% undervalued | 29.4% | €18.0B | €1,145.0M | (0.8%) | 6.4% | 43.1% | (4.2%) | 63.4% | |
$22.4B | 5.8 | $185.6 67.6% undervalued | (12.1%) | $7,678.6M | $1,132.4M | 3.8% | 14.7% | 66.0% | 6.3% | 43.0% | |
$21.7B | 6.4 | $204.3 7.3% overvalued | (2.0%) | $5,398.4M | $751.4M | (0.2%) | 13.9% | 44.7% | 8.2% | 35.6% | |
$18.8B | 7.9 | $107.4 60.0% overvalued | 61.0% | $1,900.3M | $303.0M | 12.0% | 15.9% | 76.4% | 26.9% | 6.9% |
FAQ
What is Bruker Corporation (BRKR) stock rating?
As of today, Bruker Corporation has a stock rating of 5 (out of 10), which is considered Good.
is Bruker Corporation (BRKR) a good stock to buy?
As of today, Bruker Corporation has a Good stock rating, which is 1.1% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.